nodes	percent_of_prediction	percent_of_DWPC	metapath
Telmisartan—CYP2C19—Arformoterol—chronic obstructive pulmonary disease	0.134	0.321	CbGbCtD
Telmisartan—CYP2C19—Formoterol—chronic obstructive pulmonary disease	0.134	0.321	CbGbCtD
Telmisartan—CYP2C19—Prednisone—chronic obstructive pulmonary disease	0.0562	0.135	CbGbCtD
Telmisartan—ABCB1—Prednisolone—chronic obstructive pulmonary disease	0.048	0.115	CbGbCtD
Telmisartan—ABCB1—Prednisone—chronic obstructive pulmonary disease	0.0453	0.109	CbGbCtD
Telmisartan—PPARG—leg—chronic obstructive pulmonary disease	0.00725	0.311	CbGeAlD
Telmisartan—Losartan—ACE—chronic obstructive pulmonary disease	0.00195	0.472	CrCbGaD
Telmisartan—AGTR1—connective tissue—chronic obstructive pulmonary disease	0.00193	0.0826	CbGeAlD
Telmisartan—SLCO1B3—lung—chronic obstructive pulmonary disease	0.00192	0.0821	CbGeAlD
Telmisartan—PPARG—respiratory system—chronic obstructive pulmonary disease	0.0018	0.0772	CbGeAlD
Telmisartan—AGTR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00176	0.0756	CbGeAlD
Telmisartan—AGTR1—trachea—chronic obstructive pulmonary disease	0.00162	0.0693	CbGeAlD
Telmisartan—PPARG—connective tissue—chronic obstructive pulmonary disease	0.00159	0.0679	CbGeAlD
Telmisartan—PPARG—smooth muscle tissue—chronic obstructive pulmonary disease	0.00145	0.0621	CbGeAlD
Telmisartan—Losartan—CYP1A2—chronic obstructive pulmonary disease	0.00138	0.335	CrCbGaD
Telmisartan—AGTR1—lung—chronic obstructive pulmonary disease	0.00116	0.0498	CbGeAlD
Telmisartan—PPARG—lung—chronic obstructive pulmonary disease	0.000956	0.041	CbGeAlD
Telmisartan—Losartan—ALB—chronic obstructive pulmonary disease	0.000799	0.193	CrCbGaD
Telmisartan—ABCG2—lung—chronic obstructive pulmonary disease	0.000613	0.0263	CbGeAlD
Telmisartan—ABCB1—respiratory system—chronic obstructive pulmonary disease	0.000569	0.0244	CbGeAlD
Telmisartan—PPARG—Transcription factor regulation in adipogenesis—IL6—chronic obstructive pulmonary disease	0.000506	0.00504	CbGpPWpGaD
Telmisartan—CYP2C19—Melatonin metabolism and effects—CYP1A1—chronic obstructive pulmonary disease	0.000506	0.00504	CbGpPWpGaD
Telmisartan—Arthralgia—Salbutamol—chronic obstructive pulmonary disease	0.000505	0.00111	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000505	0.00503	CbGpPWpGaD
Telmisartan—Urticaria—Tiotropium—chronic obstructive pulmonary disease	0.000505	0.00111	CcSEcCtD
Telmisartan—Anxiety—Salbutamol—chronic obstructive pulmonary disease	0.000503	0.00111	CcSEcCtD
Telmisartan—Nervous system disorder—Formoterol—chronic obstructive pulmonary disease	0.000503	0.0011	CcSEcCtD
Telmisartan—Nervous system disorder—Arformoterol—chronic obstructive pulmonary disease	0.000503	0.0011	CcSEcCtD
Telmisartan—Abdominal pain—Tiotropium—chronic obstructive pulmonary disease	0.000502	0.0011	CcSEcCtD
Telmisartan—Oedema—Montelukast—chronic obstructive pulmonary disease	0.000502	0.0011	CcSEcCtD
Telmisartan—Anaphylactic shock—Montelukast—chronic obstructive pulmonary disease	0.000502	0.0011	CcSEcCtD
Telmisartan—Tachycardia—Arformoterol—chronic obstructive pulmonary disease	0.0005	0.0011	CcSEcCtD
Telmisartan—Tachycardia—Formoterol—chronic obstructive pulmonary disease	0.0005	0.0011	CcSEcCtD
Telmisartan—Discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000499	0.0011	CcSEcCtD
Telmisartan—Infection—Montelukast—chronic obstructive pulmonary disease	0.000499	0.0011	CcSEcCtD
Telmisartan—Muscular weakness—Prednisolone—chronic obstructive pulmonary disease	0.000498	0.00109	CcSEcCtD
Telmisartan—Skin disorder—Arformoterol—chronic obstructive pulmonary disease	0.000498	0.00109	CcSEcCtD
Telmisartan—Skin disorder—Formoterol—chronic obstructive pulmonary disease	0.000498	0.00109	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—LEP—chronic obstructive pulmonary disease	0.000498	0.00496	CbGpPWpGaD
Telmisartan—Hypersensitivity—Aminophylline—chronic obstructive pulmonary disease	0.000496	0.00109	CcSEcCtD
Telmisartan—Dry mouth—Salbutamol—chronic obstructive pulmonary disease	0.000494	0.00108	CcSEcCtD
Telmisartan—Nervous system disorder—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00108	CcSEcCtD
Telmisartan—Thrombocytopenia—Montelukast—chronic obstructive pulmonary disease	0.000492	0.00108	CcSEcCtD
Telmisartan—Abdominal distension—Prednisolone—chronic obstructive pulmonary disease	0.000491	0.00108	CcSEcCtD
Telmisartan—Sepsis—Prednisone—chronic obstructive pulmonary disease	0.000491	0.00108	CcSEcCtD
Telmisartan—Skin disorder—Montelukast—chronic obstructive pulmonary disease	0.000488	0.00107	CcSEcCtD
Telmisartan—Anaphylactic shock—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.00106	CcSEcCtD
Telmisartan—Oedema—Salbutamol—chronic obstructive pulmonary disease	0.000484	0.00106	CcSEcCtD
Telmisartan—Infection—Salbutamol—chronic obstructive pulmonary disease	0.000481	0.00106	CcSEcCtD
Telmisartan—Hypotension—Formoterol—chronic obstructive pulmonary disease	0.000479	0.00105	CcSEcCtD
Telmisartan—Hypotension—Arformoterol—chronic obstructive pulmonary disease	0.000479	0.00105	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCR2—chronic obstructive pulmonary disease	0.000478	0.00476	CbGpPWpGaD
Telmisartan—Pruritus—Aminophylline—chronic obstructive pulmonary disease	0.000477	0.00105	CcSEcCtD
Telmisartan—Shock—Salbutamol—chronic obstructive pulmonary disease	0.000476	0.00105	CcSEcCtD
Telmisartan—Sweating increased—Prednisolone—chronic obstructive pulmonary disease	0.000476	0.00104	CcSEcCtD
Telmisartan—ABCC2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000475	0.00473	CbGpPWpGaD
Telmisartan—Nervous system disorder—Salbutamol—chronic obstructive pulmonary disease	0.000475	0.00104	CcSEcCtD
Telmisartan—Tachycardia—Salbutamol—chronic obstructive pulmonary disease	0.000472	0.00104	CcSEcCtD
Telmisartan—Diabetes mellitus—Prednisone—chronic obstructive pulmonary disease	0.000472	0.00104	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—GCLC—chronic obstructive pulmonary disease	0.000472	0.0047	CbGpPWpGaD
Telmisartan—Skin disorder—Salbutamol—chronic obstructive pulmonary disease	0.00047	0.00103	CcSEcCtD
Telmisartan—Hypersensitivity—Tiotropium—chronic obstructive pulmonary disease	0.000468	0.00103	CcSEcCtD
Telmisartan—Hyperhidrosis—Salbutamol—chronic obstructive pulmonary disease	0.000468	0.00103	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—chronic obstructive pulmonary disease	0.000467	0.00466	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Arformoterol—chronic obstructive pulmonary disease	0.000467	0.00103	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Formoterol—chronic obstructive pulmonary disease	0.000467	0.00103	CcSEcCtD
Telmisartan—Insomnia—Formoterol—chronic obstructive pulmonary disease	0.000464	0.00102	CcSEcCtD
Telmisartan—Insomnia—Arformoterol—chronic obstructive pulmonary disease	0.000464	0.00102	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.000463	0.00462	CbGpPWpGaD
Telmisartan—Anorexia—Salbutamol—chronic obstructive pulmonary disease	0.000461	0.00101	CcSEcCtD
Telmisartan—Diarrhoea—Aminophylline—chronic obstructive pulmonary disease	0.000461	0.00101	CcSEcCtD
Telmisartan—Vascular purpura—Prednisone—chronic obstructive pulmonary disease	0.000459	0.00101	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Montelukast—chronic obstructive pulmonary disease	0.000457	0.00101	CcSEcCtD
Telmisartan—Dyspnoea—Formoterol—chronic obstructive pulmonary disease	0.000457	0.001	CcSEcCtD
Telmisartan—Dyspnoea—Arformoterol—chronic obstructive pulmonary disease	0.000457	0.001	CcSEcCtD
Telmisartan—Somnolence—Formoterol—chronic obstructive pulmonary disease	0.000456	0.001	CcSEcCtD
Telmisartan—Somnolence—Arformoterol—chronic obstructive pulmonary disease	0.000456	0.001	CcSEcCtD
Telmisartan—Insomnia—Montelukast—chronic obstructive pulmonary disease	0.000454	0.000998	CcSEcCtD
Telmisartan—Cardiac failure congestive—Prednisone—chronic obstructive pulmonary disease	0.000453	0.000994	CcSEcCtD
Telmisartan—Hypotension—Salbutamol—chronic obstructive pulmonary disease	0.000452	0.000994	CcSEcCtD
Telmisartan—Dyspepsia—Formoterol—chronic obstructive pulmonary disease	0.000451	0.000991	CcSEcCtD
Telmisartan—Dyspepsia—Arformoterol—chronic obstructive pulmonary disease	0.000451	0.000991	CcSEcCtD
Telmisartan—Paraesthesia—Montelukast—chronic obstructive pulmonary disease	0.000451	0.000991	CcSEcCtD
Telmisartan—CYP2C19—Arachidonic acid metabolism—CYP1A2—chronic obstructive pulmonary disease	0.00045	0.00449	CbGpPWpGaD
Telmisartan—Pruritus—Tiotropium—chronic obstructive pulmonary disease	0.000449	0.000987	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—TGFB2—chronic obstructive pulmonary disease	0.000447	0.00446	CbGpPWpGaD
Telmisartan—Somnolence—Montelukast—chronic obstructive pulmonary disease	0.000446	0.000981	CcSEcCtD
Telmisartan—Dizziness—Aminophylline—chronic obstructive pulmonary disease	0.000445	0.000979	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Formoterol—chronic obstructive pulmonary disease	0.000443	0.000972	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Arformoterol—chronic obstructive pulmonary disease	0.000443	0.000972	CcSEcCtD
Telmisartan—Dyspepsia—Montelukast—chronic obstructive pulmonary disease	0.000442	0.000971	CcSEcCtD
Telmisartan—Fatigue—Formoterol—chronic obstructive pulmonary disease	0.000442	0.000971	CcSEcCtD
Telmisartan—Fatigue—Arformoterol—chronic obstructive pulmonary disease	0.000442	0.000971	CcSEcCtD
Telmisartan—Musculoskeletal discomfort—Salbutamol—chronic obstructive pulmonary disease	0.000441	0.000969	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—SLC6A4—chronic obstructive pulmonary disease	0.000439	0.00437	CbGpPWpGaD
Telmisartan—Pain—Formoterol—chronic obstructive pulmonary disease	0.000438	0.000963	CcSEcCtD
Telmisartan—Constipation—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.000963	CcSEcCtD
Telmisartan—Pain—Arformoterol—chronic obstructive pulmonary disease	0.000438	0.000963	CcSEcCtD
Telmisartan—Constipation—Formoterol—chronic obstructive pulmonary disease	0.000438	0.000963	CcSEcCtD
Telmisartan—Insomnia—Salbutamol—chronic obstructive pulmonary disease	0.000438	0.000962	CcSEcCtD
Telmisartan—AGTR1—Angiopoietin receptor Tie2-mediated signaling—TNF—chronic obstructive pulmonary disease	0.000437	0.00435	CbGpPWpGaD
Telmisartan—Increased appetite—Prednisone—chronic obstructive pulmonary disease	0.000437	0.00096	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000435	0.00434	CbGpPWpGaD
Telmisartan—Paraesthesia—Salbutamol—chronic obstructive pulmonary disease	0.000435	0.000955	CcSEcCtD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CTGF—chronic obstructive pulmonary disease	0.000434	0.00433	CbGpPWpGaD
Telmisartan—Gastrointestinal disorder—Montelukast—chronic obstructive pulmonary disease	0.000433	0.000952	CcSEcCtD
Telmisartan—Fatigue—Montelukast—chronic obstructive pulmonary disease	0.000433	0.000951	CcSEcCtD
Telmisartan—Dyspnoea—Salbutamol—chronic obstructive pulmonary disease	0.000432	0.000948	CcSEcCtD
Telmisartan—PPARG—PPARA activates gene expression—CYP1A1—chronic obstructive pulmonary disease	0.000431	0.0043	CbGpPWpGaD
Telmisartan—Somnolence—Salbutamol—chronic obstructive pulmonary disease	0.00043	0.000945	CcSEcCtD
Telmisartan—Pain—Montelukast—chronic obstructive pulmonary disease	0.000429	0.000943	CcSEcCtD
Telmisartan—Acute coronary syndrome—Prednisolone—chronic obstructive pulmonary disease	0.000429	0.000943	CcSEcCtD
Telmisartan—Vomiting—Aminophylline—chronic obstructive pulmonary disease	0.000428	0.000941	CcSEcCtD
Telmisartan—Myocardial infarction—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.000937	CcSEcCtD
Telmisartan—Neuropathy peripheral—Prednisolone—chronic obstructive pulmonary disease	0.000427	0.000937	CcSEcCtD
Telmisartan—Dyspepsia—Salbutamol—chronic obstructive pulmonary disease	0.000426	0.000936	CcSEcCtD
Telmisartan—Purpura—Prednisone—chronic obstructive pulmonary disease	0.000426	0.000936	CcSEcCtD
Telmisartan—Rash—Aminophylline—chronic obstructive pulmonary disease	0.000425	0.000933	CcSEcCtD
Telmisartan—Dermatitis—Aminophylline—chronic obstructive pulmonary disease	0.000424	0.000932	CcSEcCtD
Telmisartan—Conjunctivitis—Prednisolone—chronic obstructive pulmonary disease	0.000423	0.00093	CcSEcCtD
Telmisartan—Feeling abnormal—Formoterol—chronic obstructive pulmonary disease	0.000422	0.000928	CcSEcCtD
Telmisartan—Feeling abnormal—Arformoterol—chronic obstructive pulmonary disease	0.000422	0.000928	CcSEcCtD
Telmisartan—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—CYP1A1—chronic obstructive pulmonary disease	0.000422	0.0042	CbGpPWpGaD
Telmisartan—Headache—Aminophylline—chronic obstructive pulmonary disease	0.000422	0.000927	CcSEcCtD
Telmisartan—Decreased appetite—Salbutamol—chronic obstructive pulmonary disease	0.000421	0.000924	CcSEcCtD
Telmisartan—ABCB1—trachea—chronic obstructive pulmonary disease	0.000421	0.018	CbGeAlD
Telmisartan—Dizziness—Tiotropium—chronic obstructive pulmonary disease	0.00042	0.000923	CcSEcCtD
Telmisartan—Gastrointestinal pain—Arformoterol—chronic obstructive pulmonary disease	0.000419	0.000921	CcSEcCtD
Telmisartan—Gastrointestinal pain—Formoterol—chronic obstructive pulmonary disease	0.000419	0.000921	CcSEcCtD
Telmisartan—Gastrointestinal disorder—Salbutamol—chronic obstructive pulmonary disease	0.000418	0.000918	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000418	0.00416	CbGpPWpGaD
Telmisartan—Fatigue—Salbutamol—chronic obstructive pulmonary disease	0.000417	0.000917	CcSEcCtD
Telmisartan—Constipation—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.000909	CcSEcCtD
Telmisartan—Pain—Salbutamol—chronic obstructive pulmonary disease	0.000414	0.000909	CcSEcCtD
Telmisartan—ABCG2—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000413	0.00411	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000411	0.0041	CbGpPWpGaD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000411	0.00409	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Montelukast—chronic obstructive pulmonary disease	0.000411	0.000902	CcSEcCtD
Telmisartan—Osteoarthritis—Prednisone—chronic obstructive pulmonary disease	0.00041	0.000902	CcSEcCtD
Telmisartan—Urticaria—Formoterol—chronic obstructive pulmonary disease	0.000407	0.000895	CcSEcCtD
Telmisartan—Urticaria—Arformoterol—chronic obstructive pulmonary disease	0.000407	0.000895	CcSEcCtD
Telmisartan—Body temperature increased—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00089	CcSEcCtD
Telmisartan—Body temperature increased—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00089	CcSEcCtD
Telmisartan—Abdominal pain—Arformoterol—chronic obstructive pulmonary disease	0.000405	0.00089	CcSEcCtD
Telmisartan—Abdominal pain—Formoterol—chronic obstructive pulmonary disease	0.000405	0.00089	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—SLC6A4—chronic obstructive pulmonary disease	0.000405	0.00404	CbGpPWpGaD
Telmisartan—AGTR1—G alpha (q) signalling events—EDN1—chronic obstructive pulmonary disease	0.000404	0.00403	CbGpPWpGaD
Telmisartan—Vomiting—Tiotropium—chronic obstructive pulmonary disease	0.000404	0.000887	CcSEcCtD
Telmisartan—Rash—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.00088	CcSEcCtD
Telmisartan—Dermatitis—Tiotropium—chronic obstructive pulmonary disease	0.0004	0.000879	CcSEcCtD
Telmisartan—Nausea—Aminophylline—chronic obstructive pulmonary disease	0.0004	0.000879	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—EDN1—chronic obstructive pulmonary disease	0.000399	0.00398	CbGpPWpGaD
Telmisartan—Urticaria—Montelukast—chronic obstructive pulmonary disease	0.000399	0.000876	CcSEcCtD
Telmisartan—Feeling abnormal—Salbutamol—chronic obstructive pulmonary disease	0.000399	0.000876	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—EPHX1—chronic obstructive pulmonary disease	0.000398	0.00397	CbGpPWpGaD
Telmisartan—Headache—Tiotropium—chronic obstructive pulmonary disease	0.000398	0.000874	CcSEcCtD
Telmisartan—Bradycardia—Prednisolone—chronic obstructive pulmonary disease	0.000398	0.000874	CcSEcCtD
Telmisartan—Body temperature increased—Montelukast—chronic obstructive pulmonary disease	0.000397	0.000872	CcSEcCtD
Telmisartan—Abdominal pain—Montelukast—chronic obstructive pulmonary disease	0.000397	0.000872	CcSEcCtD
Telmisartan—Face oedema—Prednisone—chronic obstructive pulmonary disease	0.000396	0.000871	CcSEcCtD
Telmisartan—Gastrointestinal pain—Salbutamol—chronic obstructive pulmonary disease	0.000396	0.00087	CcSEcCtD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A2—chronic obstructive pulmonary disease	0.000389	0.00388	CbGpPWpGaD
Telmisartan—Urticaria—Salbutamol—chronic obstructive pulmonary disease	0.000385	0.000845	CcSEcCtD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP1A2—chronic obstructive pulmonary disease	0.000384	0.00383	CbGpPWpGaD
Telmisartan—Body temperature increased—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.000841	CcSEcCtD
Telmisartan—Abdominal pain—Salbutamol—chronic obstructive pulmonary disease	0.000383	0.000841	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000383	0.00381	CbGpPWpGaD
Telmisartan—Hypersensitivity—Formoterol—chronic obstructive pulmonary disease	0.000378	0.00083	CcSEcCtD
Telmisartan—Hypersensitivity—Arformoterol—chronic obstructive pulmonary disease	0.000378	0.00083	CcSEcCtD
Telmisartan—Nausea—Tiotropium—chronic obstructive pulmonary disease	0.000377	0.000829	CcSEcCtD
Telmisartan—ABCG2—HIF-2-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000377	0.00375	CbGpPWpGaD
Telmisartan—Visual impairment—Prednisolone—chronic obstructive pulmonary disease	0.000377	0.000827	CcSEcCtD
Telmisartan—Dry skin—Prednisone—chronic obstructive pulmonary disease	0.000376	0.000827	CcSEcCtD
Telmisartan—Hypokalaemia—Prednisone—chronic obstructive pulmonary disease	0.000374	0.000821	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL13—chronic obstructive pulmonary disease	0.000373	0.00372	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—ADIPOQ—chronic obstructive pulmonary disease	0.000372	0.00371	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—HDAC2—chronic obstructive pulmonary disease	0.000371	0.00369	CbGpPWpGaD
Telmisartan—Hypersensitivity—Montelukast—chronic obstructive pulmonary disease	0.00037	0.000813	CcSEcCtD
Telmisartan—Asthenia—Arformoterol—chronic obstructive pulmonary disease	0.000368	0.000808	CcSEcCtD
Telmisartan—Asthenia—Formoterol—chronic obstructive pulmonary disease	0.000368	0.000808	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—CXCR2—chronic obstructive pulmonary disease	0.000364	0.00362	CbGpPWpGaD
Telmisartan—Pruritus—Formoterol—chronic obstructive pulmonary disease	0.000363	0.000797	CcSEcCtD
Telmisartan—Pruritus—Arformoterol—chronic obstructive pulmonary disease	0.000363	0.000797	CcSEcCtD
Telmisartan—Muscular weakness—Prednisone—chronic obstructive pulmonary disease	0.000362	0.000795	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EDN1—chronic obstructive pulmonary disease	0.000362	0.0036	CbGpPWpGaD
Telmisartan—Asthenia—Montelukast—chronic obstructive pulmonary disease	0.00036	0.000791	CcSEcCtD
Telmisartan—Abdominal distension—Prednisone—chronic obstructive pulmonary disease	0.000357	0.000785	CcSEcCtD
Telmisartan—Hypersensitivity—Salbutamol—chronic obstructive pulmonary disease	0.000357	0.000783	CcSEcCtD
Telmisartan—Pruritus—Montelukast—chronic obstructive pulmonary disease	0.000355	0.00078	CcSEcCtD
Telmisartan—AGTR1—G alpha (q) signalling events—HTR2A—chronic obstructive pulmonary disease	0.000354	0.00352	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000354	0.00352	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000351	0.0035	CbGpPWpGaD
Telmisartan—Diarrhoea—Formoterol—chronic obstructive pulmonary disease	0.000351	0.000771	CcSEcCtD
Telmisartan—Diarrhoea—Arformoterol—chronic obstructive pulmonary disease	0.000351	0.000771	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—ADRB2—chronic obstructive pulmonary disease	0.00035	0.00348	CbGpPWpGaD
Telmisartan—Arrhythmia—Prednisolone—chronic obstructive pulmonary disease	0.000349	0.000767	CcSEcCtD
Telmisartan—Asthenia—Salbutamol—chronic obstructive pulmonary disease	0.000347	0.000763	CcSEcCtD
Telmisartan—Sweating increased—Prednisone—chronic obstructive pulmonary disease	0.000346	0.000759	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—IL17A—chronic obstructive pulmonary disease	0.000344	0.00343	CbGpPWpGaD
Telmisartan—Diarrhoea—Montelukast—chronic obstructive pulmonary disease	0.000344	0.000755	CcSEcCtD
Telmisartan—Pruritus—Salbutamol—chronic obstructive pulmonary disease	0.000342	0.000752	CcSEcCtD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—RAPGEF3—chronic obstructive pulmonary disease	0.000341	0.00339	CbGpPWpGaD
Telmisartan—Erythema—Prednisolone—chronic obstructive pulmonary disease	0.00034	0.000747	CcSEcCtD
Telmisartan—Dizziness—Formoterol—chronic obstructive pulmonary disease	0.000339	0.000745	CcSEcCtD
Telmisartan—Dizziness—Arformoterol—chronic obstructive pulmonary disease	0.000339	0.000745	CcSEcCtD
Telmisartan—Dizziness—Montelukast—chronic obstructive pulmonary disease	0.000332	0.000729	CcSEcCtD
Telmisartan—Diarrhoea—Salbutamol—chronic obstructive pulmonary disease	0.000331	0.000728	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—GSTP1—chronic obstructive pulmonary disease	0.000331	0.0033	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—LEP—chronic obstructive pulmonary disease	0.000327	0.00326	CbGpPWpGaD
Telmisartan—CYP2C19—Arachidonic acid metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000327	0.00326	CbGpPWpGaD
Telmisartan—Erectile dysfunction—Prednisone—chronic obstructive pulmonary disease	0.000327	0.000718	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—HMOX1—chronic obstructive pulmonary disease	0.000326	0.00325	CbGpPWpGaD
Telmisartan—Vomiting—Arformoterol—chronic obstructive pulmonary disease	0.000326	0.000716	CcSEcCtD
Telmisartan—Vomiting—Formoterol—chronic obstructive pulmonary disease	0.000326	0.000716	CcSEcCtD
Telmisartan—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—chronic obstructive pulmonary disease	0.000325	0.00324	CbGpPWpGaD
Telmisartan—AGTR1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	0.000324	0.00323	CbGpPWpGaD
Telmisartan—Rash—Formoterol—chronic obstructive pulmonary disease	0.000323	0.00071	CcSEcCtD
Telmisartan—Rash—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.00071	CcSEcCtD
Telmisartan—Dermatitis—Arformoterol—chronic obstructive pulmonary disease	0.000323	0.000709	CcSEcCtD
Telmisartan—Dermatitis—Formoterol—chronic obstructive pulmonary disease	0.000323	0.000709	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000322	0.00321	CbGpPWpGaD
Telmisartan—Headache—Arformoterol—chronic obstructive pulmonary disease	0.000321	0.000706	CcSEcCtD
Telmisartan—Headache—Formoterol—chronic obstructive pulmonary disease	0.000321	0.000706	CcSEcCtD
Telmisartan—Dizziness—Salbutamol—chronic obstructive pulmonary disease	0.00032	0.000703	CcSEcCtD
Telmisartan—Vomiting—Montelukast—chronic obstructive pulmonary disease	0.000319	0.000701	CcSEcCtD
Telmisartan—Rash—Montelukast—chronic obstructive pulmonary disease	0.000317	0.000696	CcSEcCtD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HTR2A—chronic obstructive pulmonary disease	0.000316	0.00315	CbGpPWpGaD
Telmisartan—Dermatitis—Montelukast—chronic obstructive pulmonary disease	0.000316	0.000695	CcSEcCtD
Telmisartan—Ill-defined disorder—Prednisolone—chronic obstructive pulmonary disease	0.000316	0.000693	CcSEcCtD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	0.000316	0.00314	CbGpPWpGaD
Telmisartan—Depression—Prednisone—chronic obstructive pulmonary disease	0.000315	0.000693	CcSEcCtD
Telmisartan—Headache—Montelukast—chronic obstructive pulmonary disease	0.000315	0.000691	CcSEcCtD
Telmisartan—Acute coronary syndrome—Prednisone—chronic obstructive pulmonary disease	0.000312	0.000685	CcSEcCtD
Telmisartan—Angioedema—Prednisolone—chronic obstructive pulmonary disease	0.000311	0.000683	CcSEcCtD
Telmisartan—Myocardial infarction—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000681	CcSEcCtD
Telmisartan—Neuropathy peripheral—Prednisone—chronic obstructive pulmonary disease	0.00031	0.000681	CcSEcCtD
Telmisartan—Vomiting—Salbutamol—chronic obstructive pulmonary disease	0.000308	0.000676	CcSEcCtD
Telmisartan—Malaise—Prednisolone—chronic obstructive pulmonary disease	0.000307	0.000674	CcSEcCtD
Telmisartan—Vertigo—Prednisolone—chronic obstructive pulmonary disease	0.000306	0.000671	CcSEcCtD
Telmisartan—Rash—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.000671	CcSEcCtD
Telmisartan—Syncope—Prednisolone—chronic obstructive pulmonary disease	0.000305	0.00067	CcSEcCtD
Telmisartan—Dermatitis—Salbutamol—chronic obstructive pulmonary disease	0.000305	0.00067	CcSEcCtD
Telmisartan—Nausea—Formoterol—chronic obstructive pulmonary disease	0.000304	0.000669	CcSEcCtD
Telmisartan—Nausea—Arformoterol—chronic obstructive pulmonary disease	0.000304	0.000669	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—GSTM1—chronic obstructive pulmonary disease	0.000304	0.00303	CbGpPWpGaD
Telmisartan—Headache—Salbutamol—chronic obstructive pulmonary disease	0.000303	0.000666	CcSEcCtD
Telmisartan—AGTR1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	0.000303	0.00302	CbGpPWpGaD
Telmisartan—ABCB1—lung—chronic obstructive pulmonary disease	0.000302	0.013	CbGeAlD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—ADRB2—chronic obstructive pulmonary disease	0.0003	0.00299	CbGpPWpGaD
Telmisartan—Loss of consciousness—Prednisolone—chronic obstructive pulmonary disease	0.000299	0.000657	CcSEcCtD
Telmisartan—Nausea—Montelukast—chronic obstructive pulmonary disease	0.000298	0.000655	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—FAM13A—chronic obstructive pulmonary disease	0.000298	0.00297	CbGpPWpGaD
Telmisartan—Hypertension—Prednisolone—chronic obstructive pulmonary disease	0.000294	0.000645	CcSEcCtD
Telmisartan—ABCG2—Fluoropyrimidine Activity—TP53—chronic obstructive pulmonary disease	0.000292	0.0029	CbGpPWpGaD
Telmisartan—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—CYP1A1—chronic obstructive pulmonary disease	0.000291	0.0029	CbGpPWpGaD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—HMOX1—chronic obstructive pulmonary disease	0.00029	0.00289	CbGpPWpGaD
Telmisartan—Bradycardia—Prednisone—chronic obstructive pulmonary disease	0.000289	0.000635	CcSEcCtD
Telmisartan—Nausea—Salbutamol—chronic obstructive pulmonary disease	0.000287	0.000632	CcSEcCtD
Telmisartan—Discomfort—Prednisolone—chronic obstructive pulmonary disease	0.000286	0.000629	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—APIP—chronic obstructive pulmonary disease	0.000284	0.00283	CbGpPWpGaD
Telmisartan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	0.000283	0.00282	CbGpPWpGaD
Telmisartan—CYP2C19—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	0.000279	0.00278	CbGpPWpGaD
Telmisartan—Connective tissue disorder—Prednisone—chronic obstructive pulmonary disease	0.000279	0.000613	CcSEcCtD
Telmisartan—Anaphylactic shock—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00061	CcSEcCtD
Telmisartan—Oedema—Prednisolone—chronic obstructive pulmonary disease	0.000278	0.00061	CcSEcCtD
Telmisartan—AGTR1—GPCRs, Class A Rhodopsin-like—HTR2A—chronic obstructive pulmonary disease	0.000273	0.00272	CbGpPWpGaD
Telmisartan—Shock—Prednisolone—chronic obstructive pulmonary disease	0.000273	0.0006	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—EDN1—chronic obstructive pulmonary disease	0.000273	0.00272	CbGpPWpGaD
Telmisartan—Tachycardia—Prednisolone—chronic obstructive pulmonary disease	0.000271	0.000595	CcSEcCtD
Telmisartan—Hyperhidrosis—Prednisolone—chronic obstructive pulmonary disease	0.000268	0.00059	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—EDN1—chronic obstructive pulmonary disease	0.000268	0.00267	CbGpPWpGaD
Telmisartan—Eye disorder—Prednisone—chronic obstructive pulmonary disease	0.000265	0.000583	CcSEcCtD
Telmisartan—Flushing—Prednisone—chronic obstructive pulmonary disease	0.000264	0.000579	CcSEcCtD
Telmisartan—Angiopathy—Prednisone—chronic obstructive pulmonary disease	0.000258	0.000566	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—SERPINE1—chronic obstructive pulmonary disease	0.000257	0.00256	CbGpPWpGaD
Telmisartan—Immune system disorder—Prednisone—chronic obstructive pulmonary disease	0.000256	0.000563	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—PDE4A—chronic obstructive pulmonary disease	0.000255	0.00254	CbGpPWpGaD
Telmisartan—Arrhythmia—Prednisone—chronic obstructive pulmonary disease	0.000254	0.000557	CcSEcCtD
Telmisartan—Insomnia—Prednisolone—chronic obstructive pulmonary disease	0.000251	0.000552	CcSEcCtD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ATP2C2—chronic obstructive pulmonary disease	0.00025	0.0025	CbGpPWpGaD
Telmisartan—Paraesthesia—Prednisolone—chronic obstructive pulmonary disease	0.000249	0.000548	CcSEcCtD
Telmisartan—Mental disorder—Prednisone—chronic obstructive pulmonary disease	0.000249	0.000547	CcSEcCtD
Telmisartan—PPARG—Signaling events mediated by HDAC Class I—TNF—chronic obstructive pulmonary disease	0.000248	0.00248	CbGpPWpGaD
Telmisartan—Malnutrition—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000543	CcSEcCtD
Telmisartan—Erythema—Prednisone—chronic obstructive pulmonary disease	0.000247	0.000543	CcSEcCtD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TGFB1—chronic obstructive pulmonary disease	0.000247	0.00246	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—APIP—chronic obstructive pulmonary disease	0.000243	0.00242	CbGpPWpGaD
Telmisartan—Pain—Prednisolone—chronic obstructive pulmonary disease	0.000237	0.000522	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—HTR2A—chronic obstructive pulmonary disease	0.000234	0.00233	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL10—chronic obstructive pulmonary disease	0.000234	0.00233	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—PDE4A—chronic obstructive pulmonary disease	0.000232	0.00231	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—LEP—chronic obstructive pulmonary disease	0.000231	0.0023	CbGpPWpGaD
Telmisartan—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—chronic obstructive pulmonary disease	0.00023	0.00229	CbGpPWpGaD
Telmisartan—Ill-defined disorder—Prednisone—chronic obstructive pulmonary disease	0.000229	0.000504	CcSEcCtD
Telmisartan—CYP2C19—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	0.000229	0.00228	CbGpPWpGaD
Telmisartan—Feeling abnormal—Prednisolone—chronic obstructive pulmonary disease	0.000229	0.000503	CcSEcCtD
Telmisartan—Anaemia—Prednisone—chronic obstructive pulmonary disease	0.000228	0.000502	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—ADRB2—chronic obstructive pulmonary disease	0.000228	0.00227	CbGpPWpGaD
Telmisartan—Angioedema—Prednisone—chronic obstructive pulmonary disease	0.000226	0.000496	CcSEcCtD
Telmisartan—ABCB1—Transmembrane transport of small molecules—TRPV4—chronic obstructive pulmonary disease	0.000223	0.00222	CbGpPWpGaD
Telmisartan—Malaise—Prednisone—chronic obstructive pulmonary disease	0.000223	0.00049	CcSEcCtD
Telmisartan—Vertigo—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000488	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—LEP—chronic obstructive pulmonary disease	0.000222	0.00221	CbGpPWpGaD
Telmisartan—Syncope—Prednisone—chronic obstructive pulmonary disease	0.000222	0.000487	CcSEcCtD
Telmisartan—ABCG2—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.000222	0.00221	CbGpPWpGaD
Telmisartan—Urticaria—Prednisolone—chronic obstructive pulmonary disease	0.000221	0.000485	CcSEcCtD
Telmisartan—Loss of consciousness—Prednisone—chronic obstructive pulmonary disease	0.000217	0.000477	CcSEcCtD
Telmisartan—AGTR1—Peptide ligand-binding receptors—CXCL8—chronic obstructive pulmonary disease	0.000216	0.00215	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—NOS2—chronic obstructive pulmonary disease	0.000215	0.00215	CbGpPWpGaD
Telmisartan—Hypertension—Prednisone—chronic obstructive pulmonary disease	0.000213	0.000469	CcSEcCtD
Telmisartan—Myalgia—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000462	CcSEcCtD
Telmisartan—Arthralgia—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000462	CcSEcCtD
Telmisartan—Anxiety—Prednisone—chronic obstructive pulmonary disease	0.00021	0.000461	CcSEcCtD
Telmisartan—Unspecified disorder of skin and subcutaneous tissue—Prednisone—chronic obstructive pulmonary disease	0.000209	0.000459	CcSEcCtD
Telmisartan—Discomfort—Prednisone—chronic obstructive pulmonary disease	0.000208	0.000457	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—NOS2—chronic obstructive pulmonary disease	0.000207	0.00206	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—CTGF—chronic obstructive pulmonary disease	0.000206	0.00205	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCR2—chronic obstructive pulmonary disease	0.000206	0.00205	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisolone—chronic obstructive pulmonary disease	0.000205	0.000449	CcSEcCtD
Telmisartan—AGTR1—GPCR ligand binding—EDN1—chronic obstructive pulmonary disease	0.000204	0.00203	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000203	0.00202	CbGpPWpGaD
Telmisartan—Anaphylactic shock—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000443	CcSEcCtD
Telmisartan—Oedema—Prednisone—chronic obstructive pulmonary disease	0.000202	0.000443	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	0.000202	0.00201	CbGpPWpGaD
Telmisartan—Infection—Prednisone—chronic obstructive pulmonary disease	0.0002	0.00044	CcSEcCtD
Telmisartan—CYP2C19—Biological oxidations—GCLC—chronic obstructive pulmonary disease	0.000199	0.00199	CbGpPWpGaD
Telmisartan—Shock—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000436	CcSEcCtD
Telmisartan—Nervous system disorder—Prednisone—chronic obstructive pulmonary disease	0.000198	0.000435	CcSEcCtD
Telmisartan—Tachycardia—Prednisone—chronic obstructive pulmonary disease	0.000197	0.000433	CcSEcCtD
Telmisartan—Skin disorder—Prednisone—chronic obstructive pulmonary disease	0.000196	0.000431	CcSEcCtD
Telmisartan—Hyperhidrosis—Prednisone—chronic obstructive pulmonary disease	0.000195	0.000428	CcSEcCtD
Telmisartan—Anorexia—Prednisone—chronic obstructive pulmonary disease	0.000192	0.000422	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000188	0.00188	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000187	0.00186	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCR2—chronic obstructive pulmonary disease	0.000187	0.00186	CbGpPWpGaD
Telmisartan—Musculoskeletal discomfort—Prednisone—chronic obstructive pulmonary disease	0.000184	0.000404	CcSEcCtD
Telmisartan—Dizziness—Prednisolone—chronic obstructive pulmonary disease	0.000184	0.000403	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—GC—chronic obstructive pulmonary disease	0.000183	0.00183	CbGpPWpGaD
Telmisartan—Insomnia—Prednisone—chronic obstructive pulmonary disease	0.000182	0.000401	CcSEcCtD
Telmisartan—PPARG—Circadian rythm related genes—SERPINE1—chronic obstructive pulmonary disease	0.000181	0.00181	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	0.000181	0.00181	CbGpPWpGaD
Telmisartan—Paraesthesia—Prednisone—chronic obstructive pulmonary disease	0.000181	0.000398	CcSEcCtD
Telmisartan—AGTR1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	0.00018	0.0018	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—HTR2A—chronic obstructive pulmonary disease	0.000178	0.00178	CbGpPWpGaD
Telmisartan—Dyspepsia—Prednisone—chronic obstructive pulmonary disease	0.000178	0.00039	CcSEcCtD
Telmisartan—ABCG2—Metabolism—APIP—chronic obstructive pulmonary disease	0.000177	0.00176	CbGpPWpGaD
Telmisartan—Decreased appetite—Prednisone—chronic obstructive pulmonary disease	0.000175	0.000385	CcSEcCtD
Telmisartan—Rash—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000385	CcSEcCtD
Telmisartan—Dermatitis—Prednisolone—chronic obstructive pulmonary disease	0.000175	0.000384	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—chronic obstructive pulmonary disease	0.000174	0.00174	CbGpPWpGaD
Telmisartan—Fatigue—Prednisone—chronic obstructive pulmonary disease	0.000174	0.000382	CcSEcCtD
Telmisartan—Headache—Prednisolone—chronic obstructive pulmonary disease	0.000174	0.000382	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	0.000173	0.00172	CbGpPWpGaD
Telmisartan—SLCO1B3—SLC-mediated transmembrane transport—ALB—chronic obstructive pulmonary disease	0.000173	0.00172	CbGpPWpGaD
Telmisartan—Constipation—Prednisone—chronic obstructive pulmonary disease	0.000173	0.000379	CcSEcCtD
Telmisartan—SLCO1B3—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.00017	0.0017	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	0.000168	0.00167	CbGpPWpGaD
Telmisartan—Feeling abnormal—Prednisone—chronic obstructive pulmonary disease	0.000166	0.000365	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	0.000165	0.00165	CbGpPWpGaD
Telmisartan—Gastrointestinal pain—Prednisone—chronic obstructive pulmonary disease	0.000165	0.000362	CcSEcCtD
Telmisartan—Nausea—Prednisolone—chronic obstructive pulmonary disease	0.000165	0.000362	CcSEcCtD
Telmisartan—PPARG—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	0.000162	0.00162	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000161	0.0016	CbGpPWpGaD
Telmisartan—Urticaria—Prednisone—chronic obstructive pulmonary disease	0.00016	0.000352	CcSEcCtD
Telmisartan—Abdominal pain—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00035	CcSEcCtD
Telmisartan—Body temperature increased—Prednisone—chronic obstructive pulmonary disease	0.000159	0.00035	CcSEcCtD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	0.000159	0.00159	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GC—chronic obstructive pulmonary disease	0.000156	0.00156	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—TNF—chronic obstructive pulmonary disease	0.000151	0.00151	CbGpPWpGaD
Telmisartan—Hypersensitivity—Prednisone—chronic obstructive pulmonary disease	0.000149	0.000327	CcSEcCtD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000146	0.00146	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000145	0.00145	CbGpPWpGaD
Telmisartan—Asthenia—Prednisone—chronic obstructive pulmonary disease	0.000145	0.000318	CcSEcCtD
Telmisartan—AGTR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—chronic obstructive pulmonary disease	0.000145	0.00144	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—chronic obstructive pulmonary disease	0.000143	0.00142	CbGpPWpGaD
Telmisartan—Pruritus—Prednisone—chronic obstructive pulmonary disease	0.000143	0.000314	CcSEcCtD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	0.000142	0.00141	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	0.00014	0.00139	CbGpPWpGaD
Telmisartan—Diarrhoea—Prednisone—chronic obstructive pulmonary disease	0.000138	0.000303	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	0.000138	0.00137	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	0.000137	0.00136	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000136	0.00135	CbGpPWpGaD
Telmisartan—Dizziness—Prednisone—chronic obstructive pulmonary disease	0.000133	0.000293	CcSEcCtD
Telmisartan—AGTR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	0.000129	0.00128	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	0.000128	0.00128	CbGpPWpGaD
Telmisartan—Vomiting—Prednisone—chronic obstructive pulmonary disease	0.000128	0.000282	CcSEcCtD
Telmisartan—ABCB1—Allograft Rejection—CXCL8—chronic obstructive pulmonary disease	0.000128	0.00127	CbGpPWpGaD
Telmisartan—Rash—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000279	CcSEcCtD
Telmisartan—Dermatitis—Prednisone—chronic obstructive pulmonary disease	0.000127	0.000279	CcSEcCtD
Telmisartan—CYP2C19—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	0.000127	0.00126	CbGpPWpGaD
Telmisartan—Headache—Prednisone—chronic obstructive pulmonary disease	0.000126	0.000278	CcSEcCtD
Telmisartan—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	0.000124	0.00123	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—IL1B—chronic obstructive pulmonary disease	0.000123	0.00122	CbGpPWpGaD
Telmisartan—PPARG—Adipogenesis—IL6—chronic obstructive pulmonary disease	0.000122	0.00122	CbGpPWpGaD
Telmisartan—CYP2C19—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	0.000122	0.00121	CbGpPWpGaD
Telmisartan—CYP2C19—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	0.00012	0.0012	CbGpPWpGaD
Telmisartan—Nausea—Prednisone—chronic obstructive pulmonary disease	0.00012	0.000263	CcSEcCtD
Telmisartan—ABCB1—HIF-1-alpha transcription factor network—VEGFA—chronic obstructive pulmonary disease	0.00012	0.00119	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	0.000117	0.00117	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	0.000117	0.00117	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	0.000116	0.00115	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	0.000115	0.00115	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GC—chronic obstructive pulmonary disease	0.000114	0.00114	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—LEP—chronic obstructive pulmonary disease	0.000113	0.00112	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	0.00011	0.0011	CbGpPWpGaD
Telmisartan—AGTR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	0.00011	0.0011	CbGpPWpGaD
Telmisartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	0.00011	0.00109	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	0.000106	0.00106	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	0.000105	0.00104	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	0.000104	0.00104	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—VEGFA—chronic obstructive pulmonary disease	0.000104	0.00103	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	0.000101	0.001	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTT1—chronic obstructive pulmonary disease	0.0001	0.000997	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—CTGF—chronic obstructive pulmonary disease	9.91e-05	0.000987	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GCLC—chronic obstructive pulmonary disease	9.89e-05	0.000986	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—APIP—chronic obstructive pulmonary disease	9.8e-05	0.000976	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—APIP—chronic obstructive pulmonary disease	9.56e-05	0.000953	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TGFB1—chronic obstructive pulmonary disease	9.52e-05	0.000949	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—TP53—chronic obstructive pulmonary disease	9.42e-05	0.000939	CbGpPWpGaD
Telmisartan—PPARG—Generic Transcription Pathway—SERPINE1—chronic obstructive pulmonary disease	9.38e-05	0.000935	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—HDAC2—chronic obstructive pulmonary disease	9.23e-05	0.00092	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	9.22e-05	0.000919	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	9.15e-05	0.000912	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	9.09e-05	0.000906	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CTGF—chronic obstructive pulmonary disease	9.03e-05	0.0009	CbGpPWpGaD
Telmisartan—ABCB1—Allograft Rejection—TNF—chronic obstructive pulmonary disease	8.89e-05	0.000886	CbGpPWpGaD
Telmisartan—SLCO1B3—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	8.77e-05	0.000874	CbGpPWpGaD
Telmisartan—PPARG—Circadian rythm related genes—IL6—chronic obstructive pulmonary disease	8.62e-05	0.000859	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTT1—chronic obstructive pulmonary disease	8.54e-05	0.000851	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GCLC—chronic obstructive pulmonary disease	8.44e-05	0.000841	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1A2—chronic obstructive pulmonary disease	8.32e-05	0.000829	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	8.06e-05	0.000803	CbGpPWpGaD
Telmisartan—PPARG—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	7.87e-05	0.000784	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CTGF—chronic obstructive pulmonary disease	7.7e-05	0.000768	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	7.49e-05	0.000747	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A2—chronic obstructive pulmonary disease	7.1e-05	0.000707	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	6.99e-05	0.000696	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTP1—chronic obstructive pulmonary disease	6.94e-05	0.000691	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	6.92e-05	0.000689	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—HMOX1—chronic obstructive pulmonary disease	6.84e-05	0.000682	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—MMP9—chronic obstructive pulmonary disease	6.76e-05	0.000674	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.49e-05	0.000647	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	6.44e-05	0.000641	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—GSTM1—chronic obstructive pulmonary disease	6.38e-05	0.000635	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	6.33e-05	0.000631	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GC—chronic obstructive pulmonary disease	6.31e-05	0.000629	CbGpPWpGaD
Telmisartan—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	6.27e-05	0.000625	CbGpPWpGaD
Telmisartan—AGTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	6.23e-05	0.00062	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTT1—chronic obstructive pulmonary disease	6.23e-05	0.00062	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	6.18e-05	0.000616	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GC—chronic obstructive pulmonary disease	6.16e-05	0.000614	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GCLC—chronic obstructive pulmonary disease	6.15e-05	0.000613	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	6.07e-05	0.000605	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—CYP1A1—chronic obstructive pulmonary disease	6.04e-05	0.000602	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTP1—chronic obstructive pulmonary disease	5.92e-05	0.00059	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.87e-05	0.000585	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—HMOX1—chronic obstructive pulmonary disease	5.84e-05	0.000582	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	5.73e-05	0.000571	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	5.65e-05	0.000563	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	5.62e-05	0.00056	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CTGF—chronic obstructive pulmonary disease	5.62e-05	0.00056	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	5.57e-05	0.000555	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—EGFR—chronic obstructive pulmonary disease	5.47e-05	0.000545	CbGpPWpGaD
Telmisartan—ABCG2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	5.46e-05	0.000544	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—GSTM1—chronic obstructive pulmonary disease	5.44e-05	0.000542	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	5.41e-05	0.000539	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—TNF—chronic obstructive pulmonary disease	5.2e-05	0.000519	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.17e-05	0.000516	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—CYP1A1—chronic obstructive pulmonary disease	5.16e-05	0.000514	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	5.12e-05	0.00051	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	5.03e-05	0.000501	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	4.91e-05	0.00049	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	4.7e-05	0.000468	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	4.68e-05	0.000466	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	4.61e-05	0.000459	CbGpPWpGaD
Telmisartan—PPARG—Gene Expression—SERPINE1—chronic obstructive pulmonary disease	4.52e-05	0.00045	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	4.39e-05	0.000437	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.32e-05	0.00043	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.26e-05	0.000424	CbGpPWpGaD
Telmisartan—PPARG—Developmental Biology—IL6—chronic obstructive pulmonary disease	4.2e-05	0.000419	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	4.13e-05	0.000412	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—ALB—chronic obstructive pulmonary disease	4.11e-05	0.000409	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—GSTM1—chronic obstructive pulmonary disease	3.97e-05	0.000395	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	3.94e-05	0.000393	CbGpPWpGaD
Telmisartan—SLCO1B3—Metabolism—NOS3—chronic obstructive pulmonary disease	3.93e-05	0.000392	CbGpPWpGaD
Telmisartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.87e-05	0.000386	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	3.77e-05	0.000375	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—CYP1A1—chronic obstructive pulmonary disease	3.76e-05	0.000375	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—ALB—chronic obstructive pulmonary disease	3.51e-05	0.000349	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.45e-05	0.000344	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GCLC—chronic obstructive pulmonary disease	3.41e-05	0.00034	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTT1—chronic obstructive pulmonary disease	3.37e-05	0.000335	CbGpPWpGaD
Telmisartan—PPARG—Metabolism—NOS3—chronic obstructive pulmonary disease	3.35e-05	0.000334	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	3.34e-05	0.000333	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GCLC—chronic obstructive pulmonary disease	3.33e-05	0.000332	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	3.18e-05	0.000317	CbGpPWpGaD
Telmisartan—AGTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	3.18e-05	0.000317	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CTGF—chronic obstructive pulmonary disease	3.11e-05	0.00031	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CTGF—chronic obstructive pulmonary disease	3.04e-05	0.000303	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	3.02e-05	0.000301	CbGpPWpGaD
Telmisartan—ABCB1—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	2.95e-05	0.000294	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.87e-05	0.000286	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A2—chronic obstructive pulmonary disease	2.8e-05	0.000279	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	2.71e-05	0.00027	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—ALB—chronic obstructive pulmonary disease	2.56e-05	0.000255	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	2.49e-05	0.000248	CbGpPWpGaD
Telmisartan—ABCG2—Metabolism—NOS3—chronic obstructive pulmonary disease	2.44e-05	0.000244	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	2.44e-05	0.000243	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.39e-05	0.000238	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.36e-05	0.000235	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTP1—chronic obstructive pulmonary disease	2.33e-05	0.000233	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—HMOX1—chronic obstructive pulmonary disease	2.3e-05	0.000229	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.2e-05	0.000219	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.14e-05	0.000214	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.08e-05	0.000208	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	2.05e-05	0.000204	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.03e-05	0.000203	CbGpPWpGaD
Telmisartan—AGTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	1.88e-05	0.000187	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000141	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—ALB—chronic obstructive pulmonary disease	1.38e-05	0.000138	CbGpPWpGaD
Telmisartan—CYP2C19—Metabolism—NOS3—chronic obstructive pulmonary disease	1.35e-05	0.000135	CbGpPWpGaD
Telmisartan—ABCB1—Metabolism—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000132	CbGpPWpGaD
